The private label arrangement will bring a new syringeless magnetic resonance (MR) injector to the U.S. 510(k) premarket notification has been submitted to the U.S. Food and Drug Administration
AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges.
The solution called Enterprise Edition combines a domestic cloud platform with an image
transfer and connectivity device to speed up the diagnostic process and reduce the impact
of radiology staff shortages.
The category defining Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.
Company’s vision is to develop a “digital twin” for radiology facilities to allow monitoring, simulation, and optimization of operations with software before implementation in the real world.
Speakers from remote radiology specialist OpenRad will discuss the launch of its enterprise reporting platform and outline the firm's vision for the future of teleradiology
Bracco’s attendance at RSNA follows FDA approval of Gadopiclenol injection, a novel macrocyclic high-relaxivity gadolinium-based contrast agent which will be commercialized as VUEWAYTM (gadopiclenol) injection by Braccoi, ii
This groundbreaking breast imaging technology helps clinicians confidently characterize breast masses, potentially saving patients time, money, and anxiety
The category-defining Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.
